Ethical, legal and social implications of rare diseases and orphan drugs in Europe: meeting report of a Brocher symposium

E Picavet, D Cassiman, W Pinxten, S Simoens

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

As part of the Scientific Program of the Fondation Brocher, a two-day symposium on orphan drugs and rare diseases was held on the shores of Lac Leman in Geneva. Specific focus was on the ethical, legal and social implications of rare diseases and orphan drugs in Europe. The symposium gathered about 30 international stakeholders and experts, representing different scientific disciplines, the pharmaceutical industry and patient representatives.
Original languageUndefined/Unknown
Pages (from-to)571-573
Number of pages3
JournalFuture Drugs
Volume13
Issue number5
DOIs
Publication statusPublished - 2013
Externally publishedYes

Research programs

  • EMC OR-01-74-01

Cite this